ClinicalTrials.gg
Not yet recruitingNCT07306923Updated Dec 29, 2025

Resilience Training Intervention: Its Effect on Parental Acceptance/Rejection and Burden of Children With Down Syndrome

An interventional study of resilience training intervention in Down Syndrome, sponsored by Ain Shams University. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-29.

Sponsored by Ain Shams University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Down Syndrome with a site in Egypt — 5 open to participants now, 7 under way, none of them phase 3. Down Syndrome · Egypt.

Planned enrollment
5th of 15
50 · median 40
Started
2025
with 5 others
No phase
14 of 21
3 open now
Registered
16th of 21
by date
Lead sponsor
1 of 21
Ain Shams University

Among the 21 studies in Down Syndrome with a site in Egypt, this one is the 5th largest by planned enrollment of the 15 interventional ones that give a count, is one of 6 that started in 2025, is one of 14 with no phase, and was the 16th registered.

Down Syndrome

439 studies on the registry are indexed under Down Syndrome; 99 are open to participants now.

Browse Down Syndrome studies →

Open to participants now

5 of the 21 studies in Down Syndrome with a site in Egypt are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 74 Down Syndrome studies recruiting now, 14 (19%) set no upper age limit and 57 (77%) stop at 75 or younger; 60 take children under 18; 19 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Down Syndrome with a site in Egypt, or all of them as a file.
02

Study summary

This research will test whether a resilience training program can help parents of children with Down syndrome feel more accepting of their child and experience less caregiving burden.

Parents who care for a child with Down syndrome often face stress and emotional challenges. Building psychological resilience-the ability to adapt and recover from stress-may improve how parents cope and relate to their children.

The study will include about 50 parents of children with Down syndrome. Participants will be randomly assigned to one of two groups:

Experimental group: Receives the resilience training program.

Control group: Receives usual care.

Study phases

Before the program: Parents complete questionnaires that measure their resilience, their acceptance or rejection of their child, and their caregiving burden.

During the program: Parents in the experimental group attend a structured resilience training program based on their expressed needs.

After the program: The same questionnaires are repeated immediately after the program and again at a follow-up to see if any changes last.

The research hypothesis is that parents who take part in the resilience training will show higher acceptance, lower rejection, and reduced caregiving burden compared with parents who receive usual care.

This study will provide evidence on whether resilience training is a helpful, practical, and safe way to support families raising a child with Down syndrome.

Read the detailed description

This quasi-experimental study will evaluate the effectiveness of a resilience training intervention on parental acceptance/rejection and caregiving burden among parents of children with Down syndrome.

Design

A non-randomized, controlled, pretest-posttest, repeated-measures design will be used. Approximately 50 parents will be allocated into an experimental group and a control group, based on availability and willingness to participate. Measurements will be taken at baseline, immediately post-intervention, and at follow-up.

Study Phases

Phase 1 - Needs assessment and program development

Assess baseline resilience, parental acceptance/rejection, and caregiving burden.

Develop and implement a tailored resilience training intervention based on identified needs.

Phase 2 - Evaluation

Evaluate the intervention's effect on parental acceptance/rejection.

Evaluate the intervention's effect on parental caregiving burden.

Intervention

The experimental group will receive a structured resilience training program designed to enhance coping skills, positive reframing, and stress management. The control group will continue with usual care during the same period.

Sample Size and Power

The required sample size was calculated a priori using G*Power 3.1.9.7 for a repeated-measures ANOVA (within-between interaction) with two groups and three time points.

Assuming a medium effect size (Cohen's f = 0.25), α = 0.05, power = 0.95, correlation among repeated measures = 0.50, and nonsphericity correction ε = 1.0, the analysis indicated 44 participants (22 per group).

To account for about 10% attrition, 50 participants (25 per group) will be recruited.

Expected Outcome

It is hypothesized that the resilience training will increase parental acceptance and reduce rejection and burden compared with usual care, despite the non-random allocation. Findings may guide family-centered mental-health programs for parents of children with Down syndrome.

03

Conditions studied

  • Down Syndrome

Keywords

  • resilience training
  • parental acceptance
  • parental burden
  • caregiver stress
  • behavioral intervention
  • psychological resilience
  • parental rejection
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Biological parent (mother or father) of a child (birth to 3 years old) diagnosed with Down syndrome.
  • Age 18 years or older.
  • Able to read and understand the study questionnaires and provide .
  • Willing to attend all resilience training sessions (for the experimental group).
  • parents who are not responsible for caring of any other patients in the family

Exclusion criteria

Exclusion Criteria:

  • Presence of severe mental illness (e.g., psychosis) or cognitive impairment that would hinder participation.
  • Current enrollment in another structured psychological or parenting program aimed at resilience or acceptance.
  • Any acute medical condition preventing attendance of the sessions.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Resilience Training Intervention (experimental)

    Resilience Training Intervention

    Behavioral: resilience training intervention

  • No intervention
    Usual Care (Control)

    Usual Care

Interventions

  • Behavioralresilience training intervention

    A structured resilience training program delivered to parents of children with Down syndrome. The program consists of sessions designed to improve psychological resilience, enhance parental acceptance, and reduce caregiving burden. Training methods may include group discussions, skill-building exercises, and home practice tasks.

06

What researchers measure

Primary outcomes

  1. Parental Acceptance-Rejection scale

    Mean change in parental acceptance-rejection score of parents of children with Down syndrome, measured using the Parental Acceptance-Rejection Questionnaire (PARQ) at baseline, immediately post-intervention, and 1-month follow-up.

    Time frame: Baseline (pre-intervention), immediately post-intervention, and 1-month follow-up

Secondary outcomes

  1. Change in Caregiver Burden Score

    Mean change in caregiver burden using Zarit Burden Interview at baseline, immediately post-intervention, and 1-month follow-up

    Time frame: Baseline, immediately post-intervention, and 1-month follow-up

  2. Change in Maternal Resilience

    Mean change in maternal resilience measured using the Maternal Resilience Scale (MRS) at baseline, immediately post-intervention, and 1-month follow-up. Higher scores indicate greater resilience.

    Time frame: Baseline, post-intervention, 1-month follow-up

07

Study locations

1 site
  • Medical Research Centre of Excellence which is affiliated to National Research Centre (NRC).
    Cairo, Cairo Governorate 11566, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2025; primary completion for Mar 2026, 3 months later.

Of 163 non-industry interventional studies with no phase under Down Syndrome, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 33. This study's planned 3 months is below that.

Counting every sponsor, half of 165 studies reached it within 11 months; a quarter within 3 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 14, 2025
First posted
Dec 29, 2025
StartEst.
Dec 2025
Primary completionEst.
Mar 2026
CompletionEst.
Apr 2026
Last update
Dec 29, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07306923
Responsible party
Sponsor
First posted
Dec 29, 2025
Start date
Dec 2025 (estimated)
Primary completion
Mar 2026 (estimated)
Completion
Apr 2026 (estimated)
Last update
Dec 29, 2025

Study contacts

Fatma Mohammed Ibrahim Morsy, assistant professor
Contact
dr.fatma.ibrahim@nursing.asu.edu.eg
+201144500853

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion